RawsGear Manufacturer

Specialize in anabolic steroids, body-building supplements and Steroid Hormone Raw Powder

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home ProductsAnti Estrogen Steroids

Anti Estrogen Steroids Letrozole Powder Femara CAS 112809-51-5 For Breast Cancer

Certification
China RawsGear Manufacturer certification
China RawsGear Manufacturer certification
As usual, you are on top of business with professionalism. Thank you for the prompt service. Look fwd to next.

—— Milton Rojas

The quality is sooo stable while order from your guys these years,it is amazing quality ,I will never change my source cos it bring me good feedback!!

—— Alex Clinton

I'm Online Chat Now

Anti Estrogen Steroids Letrozole Powder Femara CAS 112809-51-5 For Breast Cancer

China Anti Estrogen Steroids Letrozole Powder Femara CAS 112809-51-5 For Breast Cancer supplier
Anti Estrogen Steroids Letrozole Powder Femara CAS 112809-51-5 For Breast Cancer supplier Anti Estrogen Steroids Letrozole Powder Femara CAS 112809-51-5 For Breast Cancer supplier

Large Image :  Anti Estrogen Steroids Letrozole Powder Femara CAS 112809-51-5 For Breast Cancer

Product Details:

Place of Origin: China
Brand Name: RawsGear
Certification: ISO9001,Kosher , GMP , COA
Model Number: 112809-51-5

Payment & Shipping Terms:

Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: discreet packing or according to your requirement
Delivery Time: within 24 hrs after receiving your payment
Payment Terms: T/T, Western U, MG, Bitcoins, ETH, USDT
Supply Ability: mass stock
Contact Now
Detailed Product Description
Product Name: Letrozole Alias: Femara
Usage: Anti-cancer Specification: Orals
Storage Temp.: 2-8°C Whatsapp: +8618186204104
High Light:

human growth steroids

,

hgh human growth hormone

 

Anti Estrogen Steroids Letrozole Powder Femara CAS 112809-51-5 For Breast Cancer

 

Quick details

 

Letrozole CAS No. 112809-51-5
Melting point:  181-183°C
Boiling point:  563.5±60.0 °C(Predicted)
MF: C17H11N5
MW: 285.3
Density:  1.21±0.1 g/cm3(Predicted)
Solubility:  DMSO: >50mg/mL
Appearance:  White powder
Color:  white to off-white

Uses: A nonsteroidal aromatase inhibitor structurally related to Fadrozole. Antineoplastic

 

 

Letrozole Descriptions

 

Letrozole (Femara) is an orally active nonsteroidal aromatase inhibitor. As a competitive inhibitor of the aromatase, Letrozole inhibits the conversion of androgens to estrogen (estrogen stimulates breast tissues and breast cancer reoccurrence) and gonadal steroidogenesis. It can be used for the treatment of breast cancer that is hormonally-responsive or has an unknown receptor status in postmenopausal women. Besides this, Letrozole also has some off-label use such as ovarian stimulation, pretreatment of termination of pregnancy, treatment of gynecomastia, treatment of endometriosis, and promoting spermatogenesis for male patients of nonobstructive azoospermia.

 

Letrozole uses
 
Letrozole is part of a new generation of highly selective aromatase inhibitors and is an artificially synthesized benzotriazole derivative. Letrozole inhibits aromatase to lower estrogen levels, thus preventing estrogen from stimulating tumor growth. Its in vivo activity is 150-250 times stronger than that of first generation aromatase inhibitor Amarante. As it is highly selective, it will not impact glucocorticoid, mineralocorticoid and thyroid functions; even at high dosages, it will not have any inhibiting effects on adrenal corticosteroid secretion, giving it a high treatment index. Letrozole has no latent toxicity towards any bodily systems and target organs, has no mutagenicity and carcinogenic effects, has minimal toxic side effects, is well-tolerated, and has stronger anticancer effects than other aromatase inhibitors and antiestrogen drugs. Letrozole is suitable for advanced breast cancer postmenopausal patients who have not responded to estrogen-suppressing treatment and for early breast cancer treatment. It is used to treat postmenopausal patients with advanced breast cancer and serves as a second-line treatment to follow unsuccessful antiestrogen treatment. Compared to the current standard Tamoxifen treatment, Letrozole can better prevent the risk of breast cancer recurrence.

 

Letrozole product show 

 

Anti Estrogen Steroids Letrozole Powder Femara CAS 112809-51-5 For Breast Cancer 0

 

Related products 

 

Tamoxifen Citrate (Nolvadex) 54965-24-1
Clomiphene citrate 50-41-9
Exemestane (Aromasin) 107868-30-4
Anastrozole (Arimidex) 120511-73-1
Letrazole(Femara) 112809-51-5

 

 

How to contact us 

 

Our manager -- Cameron
Email: China@rawsgear.com

Whatsapp +8618186204104

Wicker: aasrawpowder

Wicker: rawsgearo1

Contact Details
RawsGear Manufacturer

Contact Person: Cameron

Send your inquiry directly to us (0 / 3000)